UNION CITY, Calif.--(BUSINESS WIRE)--Questcor Pharmaceuticals, Inc. (AMEX:QSC) today announced it will provide an update on the progress of its revised strategy for H.P. Acthar® Gel by filing a Form 8-K on Friday, January 4, 2008 prior to market open and during a conference call that will be conducted on the same day beginning at 11:00 am ET.
